ABMD Stock Price, Chart, Stats & News

Abiomed, Inc.
Save
17.18B
Market cap
65.36x
Current P/E
–
Forward P/E
ABMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 81.76% |
Operating margin | 36.12% |
Pretax margin | 18.47% |
Net margin | 13.23% |
Effective tax rate | 28.37% |
ROA | 8.16% |
ROE | 9.64% |
D/E | – |
Interest coverage ratio | 7.48x |
ABMD valuation
P/E | 65.36x |
P/S | 16.65x |
P/B | 11.52x |
P/CF | 60.67x |
P/FCF | 68.83x |
P/OCF | 60.67x |
PEG | 1.27x |
EV multiple | 34.60x |
About
Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny percutaneous heart pump featuring an integrated motor and sensors, alongside the Impella CP, which is utilized by interventional cardiologists in catheterization labs and by cardiac surgeons during operations.
Similar securities
Based on sector and market capitalization
Report issue











